Mettler-Toledo International Inc. (MTD)
NYSE·Healthcare·Medical - Diagnostics & Research
$1,263.69
-0.86%
Mkt Cap $26.92B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 5, 2026 | $1.10B | $1.13B | +2.31% | $12.80 | $13.36 | +4.37% | — | — |
| Q4 2025 Nov 6, 2025 | $997.29M | $1.03B | +3.25% | $10.66 | $11.15 | +4.60% | — | — |
| Q3 2025 Jul 31, 2025 | $957.65M | $983.22M | +2.67% | $9.60 | $10.09 | +5.10% | — | — |
| Q2 2025 May 1, 2025 | $876.56M | $883.74M | +0.82% | $7.88 | $8.19 | +3.93% | — | — |
| Q1 2025 Feb 6, 2025 | $1.01B | $1.05B | +3.57% | $11.72 | $12.41 | +5.89% | — | — |
| Q4 2024 Nov 8, 2024 | $944.75M | $954.53M | +1.04% | $10.01 | $10.21 | +2.00% | — | — |
| Q3 2024 Aug 1, 2024 | $929.13M | $946.75M | +1.90% | $9.03 | $9.65 | +6.87% | — | — |
| Q2 2024 May 9, 2024 | $879.72M | $925.95M | +5.25% | $7.64 | $8.89 | +16.36% | — | — |
| Q1 2024 Feb 8, 2024 | $959.45M | $934.99M | -2.55% | $10.10 | $9.40 | -6.93% | — | — |
| Q4 2023 Nov 9, 2023 | $952.04M | $942.46M | -1.01% | $9.74 | $9.80 | +0.62% | — | — |
| Q3 2023 Jul 27, 2023 | $1.04B | $982.12M | -6.02% | $9.97 | $10.19 | +2.21% | — | — |
| Q2 2023 May 4, 2023 | $918.72M | $928.74M | +1.09% | $8.60 | $8.69 | +1.05% | — | — |
| Q1 2023 Feb 9, 2023 | $1.03B | $1.06B | +2.66% | $11.66 | $12.10 | +3.77% | — | — |
| Q4 2022 Nov 3, 2022 | $972.09M | $985.85M | +1.41% | $9.83 | $10.18 | +3.56% | — | — |
| Q3 2022 Jul 28, 2022 | $951.52M | $978.39M | +2.82% | $8.76 | $9.39 | +7.19% | — | — |
| Q2 2022 May 5, 2022 | $868.48M | $897.79M | +3.37% | $7.25 | $7.87 | +8.55% | — | — |
| Q1 2022 Feb 10, 2022 | $1.02B | $1.04B | +1.57% | $10.08 | $10.53 | +4.46% | — | — |
| Q4 2021 Nov 4, 2021 | $924.94M | $951.95M | +2.92% | $8.24 | $8.72 | +5.83% | — | — |
| Q3 2021 Jul 29, 2021 | $875.31M | $924.35M | +5.60% | $7.62 | $8.10 | +6.30% | — | — |
| Q2 2021 May 6, 2021 | $757.85M | $804.39M | +6.14% | $5.61 | $6.56 | +16.93% | — | — |